WuXi Biologics (Cayman) I...

OTC: WXIBF · Real-Time Price · USD
4.00
0.10 (2.56%)
At close: Aug 15, 2025, 12:21 PM
3.90
-2.50%
After-hours: Aug 13, 2025, 08:00 PM EDT

WuXi Biologics (Cayman) Cash Flow Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Net Income
4.83B 3.2B 3.4B 3.59B 5.36B 5.02B 3.39B 2.79B
Depreciation & Amortization
1.44B 1.37B 1.17B 884.41M 800.67M 650.61M 481.78M 421.28M
Stock-Based Compensation
1.22B 1.33B 1.27B 1.33B 1.3B 954.84M 577.95M 378.45M
Other Working Capital
-1.16B -150.57M -301.13M -250.71M -476.35M -927.99M -551.77M 4.23M
Other Non-Cash Items
-1.47B -1.81B -279.1M 3.16B -876.68M -818.64M 1.76B 756.12M
Deferred Income Tax
n/a n/a n/a 1.3B n/a -1.3B n/a 2.32B
Change in Working Capital
-800.5M -448.17M -896.35M -2.55B -974.47M -1.65B -2.78B -2.1B
Operating Cash Flow
5.22B 3.64B 4.67B 6.42B 5.54B 4.09B 3.43B 2.25B
Capital Expenditures
-3.93B -3.98B -4.23B -5.3B -5.87B -5.12B -6.51B -7.18B
Cash Acquisitions
n/a n/a n/a -1.04M -131.49M -275.81M -2.18B -2.19B
Purchase of Investments
-11.43B -7.54B -15.08B -7.54B -10.77B -10.77B n/a n/a
Sales Maturities Of Investments
10.89B 7.82B 15.64B 7.82B 10.49B 10.49B n/a n/a
Other Investing Acitivies
524.28M 1.62B 261.99M -229.54M 377.56M 1.46B -913.26M -1.55B
Investing Cash Flow
-3.94B -2B -3.23B -5.16B -5.91B -4.22B -9.6B -10.93B
Debt Repayment
490.1M -409.23M -818.45M -409.23M -295.02M -295.02M n/a n/a
Common Stock Repurchased
-1.77B -1.69B -916.92M -2.57B -2.8B -3.21B -2.52B n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-1.49B 1.61B 3.7B 1.59B 507.88M 278.17M 10.73B 16.74B
Financial Cash Flow
-2.75B -495M 1.96B -1.39B -2.59B -3.23B 8.21B 16.74B
Net Cash Flow
8.28B 3.02B 6.55B 2.4B -3.48B -3.75B -906.47M 1.93B
Free Cash Flow
1.29B -346.67M 437.2M 1.12B -326.72M -1.03B -3.08B -4.94B